| Surfactant replacement therapy in acute respiratory distress syndrome from viral pneumonia. | |
| | |
MedLine Citation:
|
PMID: 8814477 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
A modified natural surfactant was administered to a patient with life-threatening adult respiratory distress syndrome caused by viral pneumonia. Subsequently, there was a marked improvement in gas exchange. In order to assess the mechanism for improved oxygenation, computed tomography of the lungs was done. Quantitative analysis of the scans taken before and after surfactant administration indicates that improvement in gas exchange was largely due to the expansion of underinflated and collapsed lung areas. Although this is a single case report, it provides insight into the possible beneficial effect of instilled surfactant in severe respiratory distress from viral pneumonia. |
| | |
Authors:
|
G Putz; C Hörmann; W Koller; G Schön |
Related Documents
:
|
2105627 - Determinants of hospital charges for coronary artery bypass surgery: the economic conse... 23170097 - Predictors of long-term survival in acute coronary syndrome patients with left ventricu... 4007497 - Managing asthma and copd in patients with cardiovascular disease. 17670657 - Successful extracardiac total cavo pulmonary connection (tcpc) after external tracheobr... 22678767 - Mechanisms underlying the autonomic modulation of ventricular fibrillation initiation-t... 21089117 - Preimplant left ventricular end-diastolic dimension and body weight independently assoc... |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Intensive care medicine Volume: 22 ISSN: 0342-4642 ISO Abbreviation: Intensive Care Med Publication Date: 1996 Jun |
Date Detail:
|
Created Date: 1996-12-10 Completed Date: 1996-12-10 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 7704851 Medline TA: Intensive Care Med Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 588-90 Citation Subset: IM |
Affiliation:
|
Division of Surgical and General Intensive Care Medicine, Clinic for Anesthesia, General Intensive Care Medicine, Innsbruck, Austria. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Biological Products* Child, Preschool Humans Male Phospholipids* Pneumonia, Viral / complications Pulmonary Gas Exchange / drug effects Pulmonary Surfactants / therapeutic use* Respiratory Distress Syndrome, Adult / etiology, therapy* Tomography, X-Ray Computed |
| Chemical | |
Reg. No./Substance:
|
0/Biological Products; 0/Phospholipids; 0/Pulmonary Surfactants; 129069-19-8/poractant alfa |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Haemodynamic study as guideline for the use of beta blockers in acute theophylline poisoning.
Next Document: What is the cause of pulmonary oedema after acute myocardial infarction? A case study.